Miruvor
Sign up
The short answer

What studies of gluten-free diet found

3papers on gluten-free diet
1 (few people)person in 1 study testing gluten-free diet alone
0randomised trials, the strongest kind of study

At a glance, by condition

ME/CFS: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty): 2 findings, all C.

2 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Gluten-free diet might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 3 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Gluten-free diet · ME/CFS is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

ME/CFS

Daily life and health overall

Daily functioning1 study · 1 (few people) person took gluten-free diet Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · Six months after starting the diet (few people)

Daily functioning improved.

The evidence is very uncertain about the effect of gluten-free diet on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Fibromyalgia and Chronic Fatigue Syndrome Caused by Non-Celiac Gluten Sensitivity (2014)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    continued working and practiced sports
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 1 (few people) person took gluten-free diet Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · Six months after starting the diet (few people)

Overall symptoms improved.

The evidence is very uncertain about the effect of gluten-free diet on overall symptoms in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Fibromyalgia and Chronic Fatigue Syndrome Caused by Non-Celiac Gluten Sensitivity (2014)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    remission of fibromyalgia
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Side effects

No study of this treatment alone reported side effects we could read.

All papers

  1. Proceedings #19. Maintenance tDCS: A Case of Full and Durable Recovery from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)2017 · case report · 1 in the study
    Summary

    This conference proceeding reports a case report of one 61-year-old man with treatment-resistant progressive ME/CFS who was referred for neuromodulation. There was no comparison group. He was trained in the office and then self-administered tDCS at home daily, with anode on the left dorsolateral prefrontal cortex, cathode on the right dorsolateral prefrontal cortex, 2 mA/min, 20 minutes, 40 mA total dose, using 1.5” diameter electrode pads. After four weeks, sessions were increased to twice daily (6 AM and 12 Noon). Modafinil 200 mg provided partial relief of fatigue; later the dose was lowered to 100 mg due to insomnia, and modafinil was stopped but resumed at 100 mg daily after he felt less well. The paper reports one year of maintenance tDCS and follow-up neurophysiological studies 14 months after initial presentation. It reports significant benefit early in the day during the first month of daily tDCS, consistent benefit after twice-daily sessions, and full clinical recovery over the next few months, with improved exercise tolerance and a return to physical exercise several times each week. Before treatment, omission errors were 14.29%; after treatment, behavioral measures were within the normal rage and there were no omission errors. The patient reported sustained relief. The authors state that data were not shown for frontocentral infra-slow frequency drift.

  2. Fibromyalgia and Chronic Fatigue Syndrome Caused by Non-Celiac Gluten Sensitivity2014 · case report · 1 in the study
    Summary

    This case report describes a 40-year-old woman with a 7-year history of generalized pain and chronic fatigue who had been diagnosed with fibromyalgia and also presented chronic fatigue syndrome criteria. She was seen in a clinic. She was given a gluten-free diet. The report does not state a duration for the diet. Follow-up is reported at six months after starting the diet and at 2 years after she started the diet. There was no comparison group. Outcomes reported were a marked improvement in all of the symptoms at six months, with remission of the oral ulcers; the patient had gone back to work after a long disability period. At 2 years after she started the diet there was remission of fibromyalgia, she continued working and practiced sports. When she consumed small amounts of gluten she experienced a relapse of all of the symptoms. Withdrawals for harms were not reported. The authors state that this case reinforces the hypothesis that non-celiac gluten sensitivity is linked to fibromyalgia, citing the characteristic clinical response, a relapse after gluten consumption, the HLA typing, the presence of lymphocytic duodenitis in the duodenal biopsy and the later diagnosis of celiac disease in her daughter. The authors note that lymphocytic duodenitis is not a specific finding as it may have other causes.

  3. S5110 Persistent Gastrointestinal Dysbiosis in a Male Patient With Post-Acute COVID-19 Syndrome: A Case Report Highlighting Microbiome-Related Sequelae2025 · combination: given with other treatments · 1 in the study
    Summary

    This case report describes a 50-year-old man with post-acute COVID-19 syndrome, or long COVID, who had fatigue, brain fog, bloating, and new food intolerances after 8 separate SARS-CoV-2 infections. The text does not state where the patient was from. He was treated with nystatin, probiotics, enzymes, and a gluten-free, low-sugar diet. Treatment duration was not reported. There was no comparison group. Within 8 weeks, he reported improved energy, mental clarity, GI function, and food tolerance without adverse effects. The report does not provide numerical baseline or follow-up scores for these improvements, and no statistical comparison is reported. The authors state that the timing of symptom resolution after intervention supports further study; they also note that this is a single case without follow-up testing. The authors conclude that the patient’s improvement with targeted microbiome therapy highlights the potential of gut-directed care in long COVID. Limitations stated include that this is a single case without follow-up testing. The paper does not report randomisation, blinding, allocation concealment, or funding and conflicts.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime